Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)

SHE:301033 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	97.99	74.02	57.45	26.68	44.96	10.35
Short-Term Investments	-	-	54.48	-	-	-
Trading Asset Securities	184.57	231.81	137.85	192.82	147.07	375.57
Cash & Short-Term Investments	282.56	305.83	249.78	219.5	192.02	385.92
Cash Growth	23.33%	22.44%	13.80%	14.31%	-50.24%	77.41%
Accounts Receivable	27.37	25.03	24.16	18.08	10.42	5.32
Other Receivables	1.48	1.44	1.19	1.29	1.33	1.59
Receivables	28.84	26.46	25.36	19.37	11.75	6.91
Inventory	43.04	37.06	34.28	26.2	29.41	21.18
Prepaid Expenses	-	0.48	-	0	0.37	0.02
Other Current Assets	6.93	5.35	2.99	4.64	4.7	3.12
Total Current Assets	361.37	375.19	312.41	269.71	238.25	417.14
Property, Plant & Equipment	307.85	299.38	309.45	319.15	319.82	231.46
Long-Term Investments	65.26	96.37	60.27	83.01	30.1	-
Other Intangible Assets	64.22	68.09	63.05	70.01	51.31	54.66
Long-Term Deferred Tax Assets	8.78	9.83	7.67	4.38	0.93	4.24
Long-Term Deferred Charges	37.14	33.92	34.12	26.61	34.56	27.16
Other Long-Term Assets	56.69	12.66	12.26	14.09	69.94	12.12
Total Assets	901.3	895.44	799.23	786.97	744.92	746.78

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	12.86	16.42	7.59	31.93	32.73	32.73
Accrued Expenses	7.73	26.65	22.16	18.85	16.91	14.65
Current Portion of Long-Term Debt	0.63	-	-	3.91	26.83	-
Current Portion of Leases	-	-	1.01	1.78	1.67	2.4
Current Income Taxes Payable	11.24	2.48	8.05	7.98	0.25	1.34
Current Unearned Revenue	1.28	2.21	6.02	1.2	1.45	0.86
Other Current Liabilities	4.42	3.81	2.64	2.47	1.92	2.2
Total Current Liabilities	38.17	51.57	47.48	68.12	81.77	54.18
Long-Term Debt	-	-	-	46.43	50.3	101.67
Long-Term Leases	8.7	-	-	1.01	2.85	6.62
Long-Term Unearned Revenue	42.68	45.51	51.8	35.28	6.8	8.44
Long-Term Deferred Tax Liabilities	0.27	0.3	0.29	0.26	0.62	-
Total Liabilities	89.82	97.38	99.57	151.11	142.34	170.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	67.05	67.05	66.52	66.06	66.06	66.06
Additional Paid-In Capital	488.39	484.69	463.95	441.66	436.19	436.19
Retained Earnings	262.77	252.95	179.53	126.96	99.29	70.01
Treasury Stock	-7.89	-7.89	-11.51	-	-	-
Comprehensive Income & Other	1.17	1.26	1.18	1.18	1.04	-
Total Common Equity	811.49	798.06	699.66	635.86	602.58	572.26
Minority Interest	-	-	-	-	-	3.61
Shareholders' Equity	811.49	798.06	699.66	635.86	602.58	575.87
Total Liabilities & Equity	901.3	895.44	799.23	786.97	744.92	746.78

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	9.33	-	1.01	53.13	81.65	110.7
Net Cash (Debt)	273.23	305.83	248.77	166.36	110.37	275.22
Net Cash Growth	19.41%	22.94%	49.53%	50.73%	-59.90%	61.87%
Net Cash Per Share	4.06	4.57	3.79	2.52	1.66	4.86
Filing Date Shares Outstanding	66.31	66.75	66.17	66.06	66.06	66.06
Total Common Shares Outstanding	66.31	66.75	66.17	66.06	66.06	66.06
Working Capital	323.2	323.63	264.93	201.59	156.48	362.96
Book Value Per Share	12.24	11.96	10.57	9.63	9.12	8.66
Tangible Book Value	747.27	729.96	636.61	565.85	551.27	517.6
Tangible Book Value Per Share	11.27	10.94	9.62	8.57	8.34	7.83
Buildings	-	300.03	293.55	289.32	277.02	-
Machinery	-	75.06	77.5	73.35	68.14	43.18
Construction In Progress	-	-	-	0.05	0.02	201.95

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 2, 2026

Data Sources Report a data error